Works matching IS 08876924 AND DT 2013 AND VI 27 AND IP 1

Results: 41

The novel tribody [(CD20)(2)xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

Published in:

2013

By:

Glorius P;
Baerenwaldt A;
Kellner C;
Staudinger M;
Dechant M;
Stauch M;
Beurskens FJ;
Parren PW;
Winkel JG;
Valerius T;
Humpe A;
Repp R;
Gramatzki M;
Nimmerjahn F;
Peipp M

Publication type:

Journal Article

Prognostic utility of intact immunoglobulin Ig'κ/Ig'λ ratios in multiple myeloma patients.

Published in:

2013

By:

Bradwell A;
Harding S;
Fourrier N;
Mathiot C;
Attal M;
Moreau P;
Harousseau JL;
Avet-Loiseau H;
Bradwell, A;
Harding, S;
Fourrier, N;
Mathiot, C;
Attal, M;
Moreau, P;
Harousseau, J-L;
Avet-Loiseau, H

Publication type:

journal article

A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98-NSD1 fusion gene.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 245, doi. 10.1038/leu.2012.230

By:

Fasan, A;
Haferlach, C;
Alpermann, T;
Kern, W;
Haferlach, T;
Schnittger, S

Publication type:

Article

Mutations of FLT3/ITD confer resistance to multiple tyrosine kinase inhibitors.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 48, doi. 10.1038/leu.2012.191

By:

Williams, A B;
Nguyen, B;
Li, L;
Brown, P;
Levis, M;
Leahy, D;
Small, D

Publication type:

Article

Loss of chromosomes is the primary event in near-haploid and low-hypodiploid acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 248, doi. 10.1038/leu.2012.227

By:

Safavi, S;
Forestier, E;
Golovleva, I;
Barbany, G;
Nord, K H;
Moorman, A V;
Harrison, C J;
Johansson, B;
Paulsson, K

Publication type:

Article

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 66, doi. 10.1038/leu.2012.219

By:

Etchin, J;
Sun, Q;
Kentsis, A;
Farmer, A;
Zhang, Z C;
Sanda, T;
Mansour, M R;
Barcelo, C;
McCauley, D;
Kauffman, M;
Shacham, S;
Christie, A L;
Kung, A L;
Rodig, S J;
Chook, Y M;
Look, A T

Publication type:

Article

Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 92, doi. 10.1038/leu.2012.184

By:

Qiu, X;
Sun, X;
He, Z;
Huang, J;
Hu, F;
Chen, L;
Lin, P;
You, M J;
Medeiros, L J;
Yin, C C

Publication type:

Article

Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 233, doi. 10.1038/leu.2012.178

By:

Kurimoto, M;
Matsuoka, H;
Hanaoka, N;
Uneda, S;
Murayama, T;
Sonoki, T;
Nakakuma, H

Publication type:

Article

The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 100, doi. 10.1038/leu.2012.158

By:

Sun, S M;
Rockova, V;
Bullinger, L;
Dijkstra, M K;
Döhner, H;
Löwenberg, B;
Jongen-Lavrencic, M

Publication type:

Article

Risk of developing chronic lymphocytic leukemia is influenced by HLA-A class I variation.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 255, doi. 10.1038/leu.2012.173

By:

Di Bernardo, M C;
Broderick, P;
Harris, S;
Dyer, M J S;
Matutes, E;
Dearden, C;
Catovsky, D;
Houlston, R S

Publication type:

Article

BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 251, doi. 10.1038/leu.2012.199

By:

Buitenkamp, T D;
Pieters, R;
Zimmermann, M;
de Haas, V;
Richards, S M;
Vora, A J;
Mitchell, C D;
Schwab, C;
Harrison, C J;
Moorman, A V;
van den Heuvel-Eibrink, M M;
Zwaan, C M

Publication type:

Article

SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 130, doi. 10.1038/leu.2012.169

By:

Hansen, N;
Ågerstam, H;
Wahlestedt, M;
Landberg, N;
Askmyr, M;
Ehinger, M;
Rissler, M;
Lilljebjörn, H;
Johnels, P;
Ishiko, J;
Melo, J V;
Alexander, W S;
Bryder, D;
Järås, M;
Fioretos, T

Publication type:

Article

Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 226, doi. 10.1038/leu.2012.160

By:

Usmani, S Z;
Crowley, J;
Hoering, A;
Mitchell, A;
Waheed, S;
Nair, B;
AlSayed, Y;
vanRhee, F;
Barlogie, B

Publication type:

Article

Hematopoietic stem cell mobilization: updated conceptual renditions.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 24, doi. 10.1038/leu.2012.254

By:

Bonig, H;
Papayannopoulou, T

Publication type:

Article

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 82, doi. 10.1038/leu.2012.262

By:

Schnittger, S;
Eder, C;
Jeromin, S;
Alpermann, T;
Fasan, A;
Grossmann, V;
Kohlmann, A;
Illig, T;
Klopp, N;
Wichmann, H-E;
Kreuzer, K-A;
Schmid, C;
Staib, P;
Peceny, R;
Schmitz, N;
Kern, W;
Haferlach, C;
Haferlach, T

Publication type:

Article

Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 213, doi. 10.1038/leu.2012.197

By:

Ludwig, H;
Milosavljevic, D;
Zojer, N;
Faint, J M;
Bradwell, A R;
Hübl, W;
Harding, S J

Publication type:

Article

450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 150, doi. 10.1038/leu.2012.245

By:

Cahill, N;
Bergh, A-C;
Kanduri, M;
Göransson-Kultima, H;
Mansouri, L;
Isaksson, A;
Ryan, F;
Smedby, K E;
Juliusson, G;
Sundström, C;
Rosén, A;
Rosenquist, R

Publication type:

Article

The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 75, doi. 10.1038/leu.2012.229

By:

Burnett, A K;
Hills, R K;
Hunter, A E;
Milligan, D;
Kell, W J;
Wheatley, K;
Yin, J;
McMullin, M F;
Dignum, H;
Bowen, D;
Russell, N H

Publication type:

Article

A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myeloma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 220, doi. 10.1038/leu.2012.236

By:

Witzig, T E;
Laumann, K M;
Lacy, M Q;
Hayman, S R;
Dispenzieri, A;
Kumar, S;
Reeder, C B;
Roy, V;
Lust, J A;
Gertz, M A;
Greipp, P R;
Hassoun, H;
Mandrekar, S J;
Rajkumar, S V

Publication type:

Article

Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 136, doi. 10.1038/leu.2012.187

By:

Moreira, J;
Rabe, K G;
Cerhan, J R;
Kay, N E;
Wilson, J W;
Call, T G;
Leis, J F;
Jelinek, D F;
Schwager, S M;
Bowen, D A;
Hanson, C A;
Slager, S L;
Shanafelt, T D

Publication type:

Article

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 107, doi. 10.1038/leu.2012.181

By:

Giles, F J;
le Coutre, P D;
Pinilla-Ibarz, J;
Larson, R A;
Gattermann, N;
Ottmann, O G;
Hochhaus, A;
Radich, J P;
Saglio, G;
Hughes, T P;
Martinelli, G;
Kim, D-W;
Novick, S;
Gillis, K;
Fan, X;
Cortes, J;
Baccarani, M;
Kantarjian, H M

Publication type:

Article

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 252, doi. 10.1038/leu.2012.172

By:

Tilly, H;
Morschhauser, F;
Salles, G;
Casasnovas, R-O;
Feugier, P;
Molina, T J;
Jardin, F;
Terriou, L;
Haioun, C;
Coiffier, B

Publication type:

Article

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 183, doi. 10.1038/leu.2012.257

By:

Gachard, N;
Parrens, M;
Soubeyran, I;
Petit, B;
Marfak, A;
Rizzo, D;
Devesa, M;
Delage-Corre, M;
Coste, V;
Laforêt, M P;
de Mascarel, A;
Merlio, J P;
Bouabdhalla, K;
Milpied, N;
Soubeyran, P;
Schmitt, A;
Bordessoule, D;
Cogné, M;
Feuillard, J

Publication type:

Article

MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 113, doi. 10.1038/leu.2012.186

By:

Giles, F J;
Swords, R T;
Nagler, A;
Hochhaus, A;
Ottmann, O G;
Rizzieri, D A;
Talpaz, M;
Clark, J;
Watson, P;
Xiao, A;
Zhao, B;
Bergstrom, D;
Le Coutre, P D;
Freedman, S J;
Cortes, J E

Publication type:

Article

The hunting of targets: challenge in miRNA research.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 16, doi. 10.1038/leu.2012.179

By:

Akbari Moqadam, F;
Pieters, R;
den Boer, M L

Publication type:

Article

HOX genes regulate Rac1 activity in hematopoietic cells through control of Vav2 expression.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 236, doi. 10.1038/leu.2012.166

By:

Breitinger, C;
Maethner, E;
Garcia-Cuellar, M-P;
Schambony, A;
Fischer, K D;
Schilling, K;
Slany, R K

Publication type:

Article

Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 241, doi. 10.1038/leu.2012.163

By:

Weston-Bell, N J;
Hendriks, D;
Sugiyarto, G;
Bos, N A;
Kluin-Nelemans, H C;
Forconi, F;
Sahota, S S

Publication type:

Article

EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 56, doi. 10.1038/leu.2012.211

By:

Konantz, M;
André, M C;
Ebinger, M;
Grauer, M;
Wang, H;
Grzywna, S;
Rothfuss, O C;
Lehle, S;
Kustikova, O S;
Salih, H R;
Handgretinger, R;
Fend, F;
Baum, C;
Kanz, L;
Quintanilla-Martinez, L;
Schulze-Osthoff, K;
Essmann, F;
Lengerke, C

Publication type:

Article

A record-based case-control study of natural background radiation and the incidence of childhood leukaemia and other cancers in Great Britain during 1980-2006.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 3, doi. 10.1038/leu.2012.151

By:

Kendall, G M;
Little, M P;
Wakeford, R;
Bunch, K J;
Miles, J C H;
Vincent, T J;
Meara, J R;
Murphy, M F G

Publication type:

Article

Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitors.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 118, doi. 10.1038/leu.2012.222

By:

Wöhrle, F U;
Halbach, S;
Aumann, K;
Schwemmers, S;
Braun, S;
Auberger, P;
Schramek, D;
Penninger, J M;
Laßmann, S;
Werner, M;
Waller, C F;
Pahl, H L;
Zeiser, R;
Daly, R J;
Brummer, T

Publication type:

Article

Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 32, doi. 10.1038/leu.2012.188

By:

Ren, M;
Qin, H;
Ren, R;
Cowell, J K

Publication type:

Article

Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 159, doi. 10.1038/leu.2012.196

By:

Sloma, I;
Imren, S;
Beer, P A;
Zhao, Y;
Lecault, V;
Leung, D;
Raghuram, K;
Brimacombe, C;
Lambie, K;
Piret, J;
Hansen, C;
Humphries, R K;
Eaves, C J

Publication type:

Article

Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 202, doi. 10.1038/leu.2012.159

By:

Bradwell, A;
Harding, S;
Fourrier, N;
Mathiot, C;
Attal, M;
Moreau, P;
Harousseau, J-L;
Avet-Loiseau, H

Publication type:

Article

A window into immunoglobulin quantitation and plasma cell disease: antigen epitopes defined by the junction of immunoglobulin heavy and light chains.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 1, doi. 10.1038/leu.2012.201

By:

Katzmann, J A;
Rajkumar, S V

Publication type:

Article

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 208, doi. 10.1038/leu.2012.189

By:

Katzmann, J A;
Clark, R;
Kyle, R A;
Larson, D R;
Therneau, T M;
Melton, L J;
Benson, J T;
Colby, C L;
Dispenzieri, A;
Landgren, O;
Kumar, S;
Bradwell, A R;
Cerhan, J R;
Rajkumar, S V

Publication type:

Article

The novel tribody [(CD20)<sub>2</sub>xCD16] efficiently triggers effector cell-mediated lysis of malignant B cells.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 190, doi. 10.1038/leu.2012.150

By:

Glorius, P;
Baerenwaldt, A;
Kellner, C;
Staudinger, M;
Dechant, M;
Stauch, M;
Beurskens, F J;
Parren, P W H I;
Winkel, J G J van de;
Valerius, T;
Humpe, A;
Repp, R;
Gramatzki, M;
Nimmerjahn, F;
Peipp, M

Publication type:

Article

Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 41, doi. 10.1038/leu.2012.176

By:

Jenkinson, S;
Koo, K;
Mansour, M R;
Goulden, N;
Vora, A;
Mitchell, C;
Wade, R;
Richards, S;
Hancock, J;
Moorman, A V;
Linch, D C;
Gale, R E

Publication type:

Article

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 142, doi. 10.1038/leu.2012.216

By:

Rawstron, A C;
Böttcher, S;
Letestu, R;
Villamor, N;
Fazi, C;
Kartsios, H;
de Tute, R M;
Shingles, J;
Ritgen, M;
Moreno, C;
Lin, K;
Pettitt, A R;
Kneba, M;
Montserrat, E;
Cymbalista, F;
Hallek, M;
Hillmen, P;
Ghia, P

Publication type:

Article

Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 238, doi. 10.1038/leu.2012.168

By:

Ostronoff, F;
Othus, M;
Ho, P A;
Kutny, M;
Geraghty, D E;
Petersdorf, S H;
Godwin, J E;
Willman, C L;
Radich, J P;
Appelbaum, F R;
Stirewalt, D L;
Meshinchi, S

Publication type:

Article

The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 10, doi. 10.1038/leu.2012.288

By:

Abdel-Wahab, O;
Dey, A

Publication type:

Article

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.

Published in:

Leukemia (08876924), 2013, v. 27, n. 1, p. 170, doi. 10.1038/leu.2012.165

By:

DiLillo, D J;
Weinberg, J B;
Yoshizaki, A;
Horikawa, M;
Bryant, J M;
Iwata, Y;
Matsushita, T;
Matta, K M;
Chen, Y;
Venturi, G M;
Russo, G;
Gockerman, J P;
Moore, J O;
Diehl, L F;
Volkheimer, A D;
Friedman, D R;
Lanasa, M C;
Hall, R P;
Tedder, T F

Publication type:

Article